Quick Takeaways
- Kynam Capital Management, LP filed SCHEDULE 13G for Vera Therapeutics, Inc. Class A common stock, $0.001 par value per share (VERA).
- Disclosed ownership: 5.4%.
- Date of event: 30 Jun 2025.
Kynam Capital Management, LP - 30 Jun 2025 SCHEDULE 13G Report for Vera Therapeutics, Inc. Class A common stock, $0.001 par value per share (VERA)
- Filing Manager
- Kynam Capital Management, LP
- Reporting Manager
- Kynam Capital Management, LP
- Symbol
- VERA
- Shares outstanding
- 63,815,400 shares
- Disclosed Ownership
- 3,426,887 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Aug 2025, 11:00:22 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Kynam Capital Management, LP disclosed 5.4% ownership in Vera Therapeutics, Inc. Class A common stock, $0.001 par value per share (VERA) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 11:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Kynam Capital Management, LP | 5.4% | 3,426,887 | 0 | 3,426,887 | Yue Tang | Managing Member | |
| Kynam Capital Management GP, LLC | 5.4% | 3,426,887 | 0 | 3,426,887 | Yue Tang | Managing Member | |
| Yue Tang | 5.4% | 3,426,887 | 0 | 3,426,887 | Yue Tang | Self |